Guangdong Zhongsheng Pha’s Weight‑Loss Claim Holds Stock Flat: Investors Cautious
Guangdong Zhongsheng Pha’s weight‑loss claims hit flat—early data, no Phase III, and a stagnant stock hint at caution for investors eyeing the obesity market.
- GUANGDONG ZHONGSHENG PHA
- China
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read